These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 22336202)

  • 21. Validation of the IASLC/ATS/ERS lung adenocarcinoma classification for prognosis and association with EGFR and KRAS gene mutations: analysis of 440 Japanese patients.
    Yoshizawa A; Sumiyoshi S; Sonobe M; Kobayashi M; Fujimoto M; Kawakami F; Tsuruyama T; Travis WD; Date H; Haga H
    J Thorac Oncol; 2013 Jan; 8(1):52-61. PubMed ID: 23242438
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Paradigm shifts in lung cancer as defined in the new IASLC/ATS/ERS lung adenocarcinoma classification.
    Travis WD; Brambilla E; Van Schil P; Scagliotti GV; Huber RM; Sculier JP; Vansteenkiste J; Nicholson AG
    Eur Respir J; 2011 Aug; 38(2):239-43. PubMed ID: 21804158
    [No Abstract]   [Full Text] [Related]  

  • 23. The correlation of the International Association for the Study of Lung Cancer (IASLC)/American Thoracic Society (ATS)/European Respiratory Society (ERS) classification with prognosis and EGFR mutation in lung adenocarcinoma.
    Yanagawa N; Shiono S; Abiko M; Ogata SY; Sato T; Tamura G
    Ann Thorac Surg; 2014 Aug; 98(2):453-8. PubMed ID: 24961844
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Why do pathological stage IA lung adenocarcinomas vary from prognosis?: a clinicopathologic study of 176 patients with pathological stage IA lung adenocarcinoma based on the IASLC/ATS/ERS classification.
    Zhang J; Wu J; Tan Q; Zhu L; Gao W
    J Thorac Oncol; 2013 Sep; 8(9):1196-202. PubMed ID: 23945388
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Extraction of radiomic values from lung adenocarcinoma with near-pure subtypes in the International Association for the Study of Lung Cancer/the American Thoracic Society/the European Respiratory Society (IASLC/ATS/ERS) classification.
    Yang SM; Chen LW; Wang HJ; Chen LR; Lor KL; Chen YC; Lin MW; Hsieh MS; Chen JS; Chang YC; Chen CM
    Lung Cancer; 2018 May; 119():56-63. PubMed ID: 29656753
    [TBL] [Abstract][Full Text] [Related]  

  • 26. IASLC/ATS/ERS International Multidisciplinary Classification of Lung Adenocarcinoma: novel concepts and radiologic implications.
    Lee HJ; Lee CH; Jeong YJ; Chung DH; Goo JM; Park CM; Austin JH
    J Thorac Imaging; 2012 Nov; 27(6):340-53. PubMed ID: 23086014
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [IASLC/ATS/ERS international multidisciplinary new classification of lung adenocarcinoma and its clinical significance].
    Feng RE
    Zhonghua Jie He He Hu Xi Za Zhi; 2012 Feb; 35(2):95-6. PubMed ID: 22455963
    [No Abstract]   [Full Text] [Related]  

  • 28. Evaluation of the new IASLC/ATS/ERS proposed classification of adenocarcinoma based on lepidic pattern in patients with pathological stage IA pulmonary adenocarcinoma.
    Nakagiri T; Sawabata N; Morii E; Inoue M; Shintani Y; Funaki S; Okumura M
    Gen Thorac Cardiovasc Surg; 2014 Nov; 62(11):671-7. PubMed ID: 24890089
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Changes in classiffication of primary lung adenocarcinoma according to reccomendations of International Association for the Study of Lung Cancer/ /American Thoracic Society/European Respiratory Society].
    Szołkowska M; Langfort R; Szczepulska-Wójcik E; Maksymiuk B
    Pneumonol Alergol Pol; 2012; 80(2):163-71. PubMed ID: 22370986
    [No Abstract]   [Full Text] [Related]  

  • 30. [Recommendation concerning the microscopic classification of lung adenocarcinoma presented by International Association for the Study of Lung Cancer, American Thoracic Society, and European Respiratory Society].
    Langfort R; Szołkowska M
    Pneumonol Alergol Pol; 2012; 80(2):99-100. PubMed ID: 22370977
    [No Abstract]   [Full Text] [Related]  

  • 31. Prognostic significance of histologic subtype in pStage I lung adenocarcinoma.
    Motono N; Matsui T; Machida Y; Usuda K; Uramoto H
    Med Oncol; 2017 Jun; 34(6):100. PubMed ID: 28432617
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The new IASLC-ATS-ERS lung adenocarcinoma classification: what the surgeon should know.
    Eguchi T; Kadota K; Park BJ; Travis WD; Jones DR; Adusumilli PS
    Semin Thorac Cardiovasc Surg; 2014; 26(3):210-22. PubMed ID: 25527015
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tissue-sparing application of the newly proposed IASLC/ATS/ERS classification of adenocarcinoma of the lung shows practical diagnostic and prognostic impact.
    Sterlacci W; Savic S; Schmid T; Oberaigner W; Auberger J; Fiegl M; Tzankov A
    Am J Clin Pathol; 2012 Jun; 137(6):946-56. PubMed ID: 22586054
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mutational Profile and New IASLC/ATS/ERS Classification Provide Additional Prognostic Information about Lung Adenocarcinoma: A Study of 125 Patients from Brazil.
    de Melo AC; Karen de Sá V; Sternberg C; Olivieri ER; Werneck da Cunha I; Fabro AT; Carraro DM; de Barros e Silva MJ; Pimenta Inada HK; de Mello ES; Soares FA; Takagaki T; Ferreira CG; Capelozzi VL
    Oncology; 2015; 89(3):175-86. PubMed ID: 25833149
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of outcomes for patients with lepidic pulmonary adenocarcinoma defined by 2 staging systems: A North American experience.
    Wilshire CL; Louie BE; Horton MP; Castiglioni M; Aye RW; Farivar AS; West HL; Gorden JA; Vallières E
    J Thorac Cardiovasc Surg; 2016 Jun; 151(6):1561-8. PubMed ID: 26897242
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical relevance of the new IASLC/ERS/ATS adenocarcinoma classification.
    Kerr KM
    J Clin Pathol; 2013 Oct; 66(10):832-8. PubMed ID: 23564952
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Advance in Diagnose and Treatment Strategies of Adenocarcinoma in Situ].
    Qiu Y; Shen-Tu Y
    Zhongguo Fei Ai Za Zhi; 2017 Sep; 20(9):641-644. PubMed ID: 28935019
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New IASLC/ATS/ERS classification and invasive tumor size are predictive of disease recurrence in stage I lung adenocarcinoma.
    Yanagawa N; Shiono S; Abiko M; Ogata SY; Sato T; Tamura G
    J Thorac Oncol; 2013 May; 8(5):612-8. PubMed ID: 23584293
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lung Adenocarcinoma Staging Using the 2011 IASLC/ATS/ERS Classification: A Pooled Analysis of Adenocarcinoma In Situ and Minimally Invasive Adenocarcinoma.
    Behera M; Owonikoko TK; Gal AA; Steuer CE; Kim S; Pillai RN; Khuri FR; Ramalingam SS; Sica GL
    Clin Lung Cancer; 2016 Sep; 17(5):e57-e64. PubMed ID: 27137345
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Interpretation of IASLC/ATS/ERS international multidisciplinary classification of lung neoplasms].
    Lin D
    Zhongguo Fei Ai Za Zhi; 2013 Jun; 16(6):277-81. PubMed ID: 23769340
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.